Key Takeaways
- • Bill Ackman attributed his "grizzled" appearance in a Bloomberg street interview to a back injury from tennis, two sleepless nights, dry skin and poor lighting, not to market losses or health problems.
- • The Pershing Square founder, 60, addressed the criticism in a Sunday post on X, which was pinned to the top of his account, after a clip of the Friday interview circulated online.
- • In the interview, Ackman discussed AI, said he was sad to see Jensen Huang leave Nvidia, and praised Anthropic CEO Dario Amodei's presentation at the company's New York IPO road show.
- • Ackman said he is recovering with help from VOSK Center, a New York performance and longevity club, using electrical stimulation, back and hip muscle work and weights, and said he does not take GLP-1 medications.
Summary
In a Sunday post on X, Ackman, 60, said he had pulled his back, could not work out for a week, and had trouble sleeping because of the pain. He joked that the resulting look made him seem a decade older and compared himself to John McEnroe, who is seven years his senior. He said his explanation involved no dramatic market losses.
The interview itself focused on artificial intelligence. Ackman told Bloomberg he was sad to see Jensen Huang leave Nvidia and said he was impressed by Anthropic CEO Dario Amodei's presentation at the company's New York IPO road show. Those remarks, according to the report, were overshadowed by discussion of his appearance.
In a follow-up update, Ackman said the team at VOSK Center, a luxury New York-based performance and longevity club that called him a founding member, helped him return to exercise through electrical stimulation, back and hip muscle work and weights. VOSK shared a video of him taking on a pull-up challenge. Ackman wrote that "the back is still stiff but I can walk again" and said he does not take GLP-1 medications, stating "I don't like drugs," while acknowledging that avoiding them made the back pain harder to manage. He closed by urging people to look out for one another.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.